The general dose escalation path looks like this: Weeks 1-4: 2.5 mg once weekly Weeks 5-8: Increase to 5 mg once weekly, if tolerated Weeks 9-12: Increase to 7.5 mg once weekly, if tolerated and needed Ongoing: Continue increasing by 2.5 mg every 4 weeks until the target maintenance dose is reached
The true risk could be barely above baseline or it could be substantially elevated, the data simply cannot pin it down with precision
In addition to ferredoxin in the chloroplast (Miyake and Asada 1994), MDHA-reducing activities have been described for a protein located at the plasma membrane and a tonoplast cytochrome b enzyme (Brczi and Mller 1998
doi:10.1001/jamainternmed.2020.0249
Lipo-Mino injections are a specialized blend of lipotropic compounds, amino acids, and key B vitamins formulated to optimize the bodys fat-processing pathways
The Bioavailability Solution: Liposomal Delivery This is where the science of formulation becomes critical